Prof. Dr. ÖZLEN ATUĞ

Yayın Ağı

Makaleler 42

1. Risk factors for stricture-related surgery in stricturing Crohn’s disease

Yunusov E., Piyade B., Ergenc I., Tasci M. E., Sariyar N., ÖZEN ALAHDAB Y., et al.

BMC Gastroenterology , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. The Impact of Fistulizing Disease, Treatment Modalities, and Clinical Activity on Health-Related Quality of Life in Crohn’s Disease

KANİ H. T., Kaldirim Armutcuoglu Y., Ergenc I., Ozsarac B., Sahin B. N., Kaya G., et al.

Digestive Diseases and Sciences , cilt.71, sa.11, ss.5737-5744, 2026 (SCI-Expanded, Scopus)

3. Comparison of Azathioprine-Induced Pancreatitis and Gastrointestinal Intolerance in IBD: Role of Demographics, Clinical Variables, and HLA DQA1/DRB1 Alleles

EŞKAZAN T., Bakkaloglu O. K., TÖRÜNER M., KANİ H. T., Cavus B., YILMAZ V., et al.

Journal of Clinical Medicine , cilt.14, sa.23, 2025 (SCI-Expanded, Scopus)

4. Behçet’s Disease with Intestinal Involvement Can be Distinguished from Inflammatory Bowel Diseases by Measurement of Common Femoral Vein Wall Thickness

SEVİK G., ERGELEN R., Ergenc I., SOYDEMİR E., TEMİZ F., ATUĞ Ö., et al.

Mediterranean Journal of Rheumatology , cilt.36, sa.2, ss.268-272, 2025 (Scopus)

5. Response to “Utility of SARC-F for screening for sarcopenia in ulcerative colitis”

Ergenc I., Ismail Basa C., Uzum A., Sahin S., KANİ H. T., Aslan R., et al.

Nutrition in Clinical Practice , cilt.39, sa.5, ss.1272-1273, 2024 (SCI-Expanded, Scopus)

6. High prevalence of muscle weakness and probable sarcopenia in patients with inflammatory bowel disease

Ergenc I., Ismail Basa C., Uzum A., Sahin S., KANİ H. T., Aslan R., et al.

Nutrition in Clinical Practice , cilt.39, sa.3, ss.557-567, 2024 (SCI-Expanded, Scopus)

7. Improving the Computer-Aided Estimation of Ulcerative Colitis Severity According to Mayo Endoscopic Score by Using Regression-Based Deep Learning

Polat G., Kani H. T., Ergenc I., ÖZEN ALAHDAB Y., TEMİZEL A., ATUĞ Ö.

INFLAMMATORY BOWEL DISEASES , cilt.29, ss.1431-1439, 2023 (SCI-Expanded, Scopus)

8. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy

Ergenç İ., KANİ H. T., KARABACAK M., CÖMERT ÖZER E., Mehdiyev S., Jafarov F., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.34, sa.3, ss.310, 2023 (SCI-Expanded, Scopus, TRDizin)

9. Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn's Disease in Routine Clinical Practice in Turkey

TÖRÜNER M., BAŞARANOĞLU M., ATUĞ Ö., Senturk O., Akyuz F., Cekic C., et al.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology , cilt.33, sa.5, ss.406-413, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

10. Hepatitis B reactivation under biologic therapy in patients with HBsAg negative phase of chronic HBV infection

Ergenc I., Kani H. T., Karabacak M., Ozer E. C., Mehdiyev S., Jafarov F., et al.

JOURNAL OF CROHNS & COLITIS , cilt.15, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. Evaluation of endoscopic mayo score with an artificial intelligence algorithm

Kani H. T., Ergenc I., Polat G., Alahdab Y. O., TEMİZEL A., Atug O.

JOURNAL OF CROHNS & COLITIS , cilt.15, 2021 (SCI-Expanded, Scopus)

12. Correlation between physician disease assessment in Ulcerative Colitis and burden of disease: ICONIC 2-year data of 120 patients in Turkey

Sezgin O., Atug O., Gonen C., Can G., Duman A. E., Erzin Y. Z., et al.

JOURNAL OF CROHNS & COLITIS , cilt.15, 2021 (SCI-Expanded, Scopus)

13. Depression and anxiety have unique contributions to somatic complaints in depression, irritable bowel syndrome and inflammatory bowel diseases

YANARTAŞ Ö., Kani H. T., Kani A., Akca Z. N. D., Akca E., Ergun S., et al.

PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , cilt.29, sa.4, ss.418-426, 2019 (SCI-Expanded, Scopus)

14. Effectiveness of "Hospital Anxiety and Depression Scale" for the screening of the psychiatric treatment need in outpatients with Inflammatory Bowel Diseases

Yanatas O., Kani H. T., Banzragch M., Bicakci E., Kuscu K., Atug O., et al.

JOURNAL OF CROHNS & COLITIS , cilt.9, 2015 (SCI-Expanded, Scopus)

15. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects

Yonal O., EREN F., YILMAZ Y., ATUĞ Ö., Over H. H.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.25, sa.6, ss.639-643, 2014 (SCI-Expanded, Scopus, TRDizin)

16. Vitamin D deficiency in inflammatory bowel disease patients

Kani H. T., Demircan N., Yazici D., Bicakci E., Banzragch M., Atug O., et al.

JOURNAL OF CROHNS & COLITIS , cilt.8, 2014 (SCI-Expanded, Scopus)

17. Sexual dysfunction in inflammatory bowel disease patients

Yanartas O., Kani H. T., Banzragch M., Bicakci E., Kani A., Atug O., et al.

JOURNAL OF CROHNS & COLITIS , cilt.8, 2014 (SCI-Expanded, Scopus)

18. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L., et al.

DIGESTIVE AND LIVER DISEASE , cilt.45, sa.1, ss.58-62, 2013 (SCI-Expanded, Scopus)

19. Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease

Eren F., Kurt R., Ermis F., Atuğ Ö., Imeryuz N., Yılmaz Y.

Clinical Biochemistry , cilt.45, ss.655-658, 2012 (SCI-Expanded, Scopus)

20. Preliminary evidence of an association between the functional c-kit rs6554199 polymorphism and achalasia in a Turkish population

Alahdab Y., Eren F., Giral A., Gunduz F., Kedrah A. E., Atug O., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , cilt.24, sa.1, ss.27-30, 2012 (SCI-Expanded, Scopus)

21. Association Between The Presence of Brown Adipose Tissue and Nonalcoholic Fatty Liver Disease in Adult Humans

Yilmaz Y., Ones T., Purnak T., Kurt R., Ozguven S., Atug O., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING , cilt.38, 2011 (SCI-Expanded, Scopus)

22. Serum levels of soluble receptor for advanced glycation endproducts (sRAGE) are higher in ulcerative colitis and correlate with disease activity

Yilmaz Y., Yonal O., Eren F., Atug O., Hamzaoglu H. O.

Journal of Crohn's and Colitis , cilt.5, sa.5, ss.402-406, 2011 (SCI-Expanded, Scopus)

23. Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans.

Yilmaz Y., Ones T., Purnak T., Ozguven S., Kurt R., Atug O., et al.

Alimentary pharmacology & therapeutics , cilt.34, sa.3, ss.318-23, 2011 (SCI-Expanded, Scopus)

24. Association between bactericidal/permeability increasing protein (BPI) gene polymorphism (Lys216Glu) and inflammatory bowel disease

Akin H., Tahan G., Ture F., EREN F., ATUĞ Ö., Tahan V., et al.

JOURNAL OF CROHNS & COLITIS , cilt.5, sa.1, ss.14-18, 2011 (SCI-Expanded, Scopus)

25. R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History

EREN F., AKKİPRİK M., ATUĞ Ö., Sonmez O., Tahan G., Ozdemir F., et al.

PATHOLOGY & ONCOLOGY RESEARCH , cilt.16, sa.4, ss.563-568, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

26. Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: Association with insulin resistance

Yılmaz Y., Ulukaya E., Atuğ Ö., Dolar E.

European Journal of Gastroenterology and Hepatology , cilt.21, ss.1247-1251, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats

Canbakan B., Akin H., Tahan G., Tarcin O., Eren F., Atug O., et al.

ANNALS OF HEPATOLOGY , cilt.8, sa.3, ss.234-240, 2009 (SCI-Expanded, Scopus)

28. Pegylated interferon/ribavirin-induced sudden sensorineural hearing loss in a patient with chronic hepatitis C

ATUĞ Ö., Akin H., YILMAZ Y., Sari M., Tozun N.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES , cilt.18, sa.2, ss.256, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Awareness of hepatitis C virus transmission routes among patients, their household contacts and health care staff: Does perception match the reality?

Tiftikci A., ATUĞ Ö., Tozun N.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.20, sa.2, ss.104-107, 2009 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

30. Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease

YILMAZ Y., ULUKAYA E., Gul O. O., Arabul M., Gul C. B., ATUĞ Ö., et al.

CLINICAL BIOCHEMISTRY , cilt.42, sa.9, ss.802-807, 2009 (SCI-Expanded, Scopus)

31. Melatonin ameliorates methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in rats

Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin O., et al.

JOURNAL OF PINEAL RESEARCH , cilt.46, sa.4, ss.401-407, 2009 (SCI-Expanded, Scopus)

32. Critical pH Level of Lye (NaOH) for Esophageal Injury

ATUĞ Ö., Dobrucali A., Orlando R. C.

DIGESTIVE DISEASES AND SCIENCES , cilt.54, sa.5, ss.980-987, 2009 (SCI-Expanded, Scopus)

33. Serum Levels of Adipokines in Patients with Chronic HCV Infection: Relationship with Steatosis and Fibrosis

Tiftikci A., ATUĞ Ö., YILMAZ Y., EREN F., Ozdemir F. T., Yapali S., et al.

ARCHIVES OF MEDICAL RESEARCH , cilt.40, sa.4, ss.294-298, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. Dipeptidyl peptidase IV inhibitors: Therapeutic potential in nonalcoholic fatty liver disease

YILMAZ Y., ATUĞ Ö., Yonal O., DUMAN D., Ozdogan O., Imeryuz N., et al.

MEDICAL SCIENCE MONITOR , cilt.15, sa.4, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. MICROSATELLITE INSTABILITY IN THE INFLAMED AND NON-NEOPLASTIC COLONIC MUCOSA IN ULCERATIVE COLITIS

ATUĞ Ö., AKKİPRİK M., EREN F., TIFTIKCI A., Ozdemir F. T., Asicioglu F., et al.

MARMARA MEDICAL JOURNAL , cilt.22, sa.1, ss.12-18, 2009 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

36. Clinical Characteristics of Inflammatory Bowel Disease in Turkey A Multicenter Epidemiologic Survey

Tozun N., ATUĞ Ö., Imeryuz N., Hamzaoglu H. O., Tiftikci A., Parlak E., et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.43, sa.1, ss.51-57, 2009 (SCI-Expanded, Scopus)

37. Proteomic analysis of serum in patients with non-alcoholic steatohepatitis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry

ULUKAYA E., YILMAZ Y., Moshkovskii S., Karpova M., Pyatnitskiy M., ATUĞ Ö., et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY , cilt.44, sa.12, ss.1471-1476, 2009 (SCI-Expanded, Scopus)

38. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARγ) gene in inflammatory bowel disease

ATUĞ Ö., Tahan V., EREN F., Tiftikci A., Imeryuz N., Hamzaoglu H. O., et al.

Journal of Gastrointestinal and Liver Diseases , cilt.17, sa.4, ss.433-437, 2008 (SCI-Expanded, Scopus)

39. Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor-gamma (PPAR gamma) Gene in Inflammatory Bowel Disease

ATUĞ Ö., Tahan V., EREN F., Tiftikci A., Imeryuz N., Hamzaoglu H. O., et al.

JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES , cilt.17, sa.4, ss.433-437, 2008 (SCI-Expanded, Scopus)

40. Esomeprazole in acute and maintenance treatment of reflux oesophagitis: a multicentre prospective study

ATUĞ Ö., GİRAL A., Kalayci C., Dolar E., Isitan F., Oguz D., et al.

ADVANCES IN THERAPY , cilt.25, sa.6, ss.552-566, 2008 (SCI-Expanded, Scopus)

41. Hyperbaric oxygen therapy is as effective as dexamethasone in the treatment of TNBS-E-induced experimental colitis

ATUĞ Ö., Hamzaoglu H., Tahan V., Alican I., Kurtkaya O., Elbuken E., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.53, sa.2, ss.481-485, 2008 (SCI-Expanded, Scopus)

42. Detection of Helicobacter pylori in bladder biopsy specimens of patients with interstitial cystitis by polymerase chain reaction

Atug F., Turkeri L., Atug O., Cal C.

UROLOGICAL RESEARCH , cilt.32, sa.5, ss.346-349, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 18

1. Sirotik Hastalarda Portal Hipertansif Gastropatinin Prevalansı ve Prediktif Değerlerinin İncelenmesi

MAMMADOVA A., TAZEGÜL G., DEMİRTAŞ C. Ö., ATUĞ Ö., ÖZDOĞAN O. C.

42. Ulusal Gastroenteroloji Haftası, Antalya, Türkiye, 25 - 30 Kasım 2025, (Özet Bildiri)

2. Class Distance Weighted Cross-Entropy Loss for Ulcerative Colitis Severity Estimation

Polat G., Ergenc I., KANİ H. T., ÖZEN ALAHDAB Y., ATUĞ Ö., TEMİZEL A.

26th Annual Conference on Medical Image Understanding and Analysis (MIUA), Cambridge, Kanada, 27 - 29 Temmuz 2022, cilt.13413, ss.157-171, (Tam Metin Bildiri)

3. MR-Entereography Findings of Intestinal Inflammation in Spondyloarethritis with high faecal calprotectin levels.

Ergenç İ., Uner E., ERGELEN R., HAKLAR G., İMERYÜZ N., ATUĞ Ö., et al.

Congress of the European-League-Against-Rheumatism (EULAR), 13 - 16 Haziran 2018, (Tam Metin Bildiri)

4. MR - ENTEROGRAPHY FINDINGS OF INTESTINAL INFLAMMATION IN SPONDYLOARTHRITIS WITH HIGH FAECAL CALPROTECTIN LEVELS

Ergenc I., Uner E., Ergelen R., Haklar G., Imeryuz N., Atug O., et al.

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Hollanda, 13 - 16 Haziran 2018, cilt.77, ss.808, (Özet Bildiri)

5. Bactericidal permeability increasing protein has no effect on remission of ulcerative colitis

EREN F., eroğlu k., Banzragch M., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.

The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016

6. MT ND5 gene variants have both protective and risk factor for inflammatory bowel disease

Eren F., Safarova C., Gündüz F., Özen Alahdab Y., Kurt R., Yılmaz Y., et al.

The 4th Annual Meeting of Asian Organization for Crohn's & Colitis, Kyoto, Japonya, 7 - 09 Temmuz 2016, (Özet Bildiri)

7. THE EPIDEMIOLOGY OF THE RHEUMATIC MANIFESTATIONS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: THE PRELIMINARY DATA FROM A HOSPITAL-BASED COHORT STUDY IN ISTANBUL

Cakir N., Imeryuz N., Atug O., Akin H.

Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1255-1256, (Özet Bildiri)

8. The effects of psychiatric treatment in patient with inflammatory bowel disease a prospective study

YANARTAŞ Ö., Kanı H. T., Bıçakçı E., BEZ Y., BANZRAGCH M., DADALI Z., et al.

11th Congress of ECCO Inflammatory Bowel Disease, 16 - 19 Mart 2016

9. Ülseratif kolitin hastalık aktivitesi bakterisidal permeabilite arttırıcı protein BPI düzeyi ile ilişkilidir

EREN F., eroğlu k., banzragch m., GÜNDÜZ F., ÖZEN ALAHDAB Y., KURT R., et al.

32. Ulusal Gastroenetroloji Haftası, Türkiye, 25 - 29 Kasım 2015

10. İNFLAMMATUAR BARSAK HASTALIĞI OLGULARINDA PSİKİYATRİK HASTALIKLAR VE TEDAVİ SONUÇLARI

YANARTAŞ Ö., KANI H. T., BIÇAKÇI E., BEZ Y., BANZRAGCH M., DADALI Z., et al.

51. Ulusal Psikiyatri Kongresi, Türkiye, 25 - 29 Kasım 2015, cilt.26, ss.13

11. Gender alters the clinical features of common anorectal disorders

Tokay S., Atug O., Akin H., Imeryuz N.

NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, cilt.27, ss.103-104, (Özet Bildiri)

12. Contribution of the Hospital Anxiety and Depression Scale for the Prediction of Psychiatric Disorder Diagnosis in IBD Outpatient Clinics and the Results of the Treatment

YANARTAŞ Ö., BIÇAKÇI E., KANI H. T., MUNKHTSETSEG B., ŞENKAL Z., KUŞÇU K., et al.

Digestive Diseases Week 2015, Washington, D.C., United States, Amerika Birleşik Devletleri, 16 - 19 Mayıs 2015, cilt.148, ss.840-0

13. Effectiveness of Hospital Anxiety and Depression Scale for the screening of the psychiatric treatment need in outpatients with Inflammatory Bowel Diseases

YANARTAŞ Ö., KANI H. T., BANZRAGCH M., BIÇAKÇI E., KUŞÇU K., ATUĞ Ö., et al.

EUROPEAN CHRON'S AND COLITIS ORGANISATIONS 2015, BARCELONA, Barcelona, İspanya, 18 Mayıs - 21 Şubat 2015

14. HASTANE ANKSİYETE VE DEPRESYON ÖLÇEĞİ İNFLAMATUAR BARSAK HASTALIĞI OLGULARINDA TEDAVİ GEREKSİNİMİNİ NE ÖLÇÜDE BELİRLİYOR

YANARTAŞ Ö., KANI H. T., BANZRAGCH M., BIÇAKÇI E., KUŞÇU K., ATUĞ Ö., et al.

11. ULUSAL HEPATO GASTROENTEROLOJİ KONGRESİ, Türkiye, 24 - 28 Eylül 2014

15. Sexual dysfunction in inflammatory bowel disease patients

YANARTAŞ Ö., KANI H. T., BANZRAGCH M., BIÇAKÇI E., SAKALLI KANI A., ATUĞ Ö., et al.

9th CONGRESS OF ECCO, 20 - 22 Şubat 2014, ss.119

16. PRELIMINARY EVIDENCE OF A REDUCED SERUM LEVEL OF FIBROBLAST GROWTH FACTOR 19 IN PATIENTS WITH BIOPSY-PROVEN NONALCOHOLIC FATTY LIVER DISEASE

Eren F., Kurt R., Ermis F., Atug O., Imeryuz N., Yilmaz Y.

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, cilt.58, (Özet Bildiri)

17. MELATONIN AMELIORATES METHIONINE CHOLINE DEFICIENT DIET INDUCED NONALCOHOLIC STEATOHEPATITIS IN RATS

Tahan V., ATUĞ Ö., Akin H., EREN F., Tahan G., Tarcin Ö., et al.

60th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 30 Ekim - 03 Kasım 2009, cilt.50, (Özet Bildiri)